PLAG alleviates chemotherapy-induced thrombocytopenia via promotion of megakaryocyte/erythrocyte progenitor differentiation in mice. Thrombosis Research 161:84-90, 2018 Explore further
PLAG (1-palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol) reduces hepatic injury in concanavalin A-treated mice. Journal of Cellular Biochemistry 119(2):1392-1405, 2018. Explore further
PLAG (1-palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol) ameliorates arthritic joints through reducing neutrophil infiltration mediated by IL-6/STAT3 and MIP-2 activation. Oncotarget 8(57):96636-96648, 2017. Explore further
The ameliorating effect of 1-palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol on scopolamine-induced memory impairment via acetylcholinesterase inhibition and LTP activation. Behavioural Brain Research 324:58-65. Explore further
The Therapeutic Effect of PLAG against Oral Mucositis in Hamster and Mouse Model. Frontiers in Oncology 6:206, 2016 Explore further
PLAG (1-palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol) augments the therapeutic effect of pegfilgrastim on gemcitabine-induced neutropenia. Cancer Letters 377: 25-31, 2016 Explore further
